Trial Profile
Randomized, double-blind, parallel group, placebo-controlled multi-center study evaluating the efficacy of PN 400 [esomeprazole/naproxen] BID and celecoxib QD in patients with osteoarthritis of the knee.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Esomeprazole/naproxen (Primary) ; Celecoxib
- Indications Musculoskeletal pain; NSAID-induced gastrointestinal damage; Osteoarthritis
- Focus Therapeutic Use
- Sponsors POZEN
- 05 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 28 Apr 2011 Results published in the Current Medical Research and Opinion.
- 26 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.